跳至主要内容
临床试验/IRCT20170417033489N4
IRCT20170417033489N4已完成2 期

The effect of autologous peripheral blood cells transplantation along with platelet rich plasma in the treatment of patients with vesicoureteral reflux

Mashhad University of Medical Sciences0 个研究点目标入组 15 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
15 years 至 35 years(—)
性别
All

入选标准

  • Patient with re flux grade 2, 3 or 4 grade
  • No surgical treatment has been performed so far

排除标准

  • The patient is in the acute phase of urinary tract infection
  • Patient with renal failure due to re flux
  • Patient with grade 1 or 5 re flux

研究者

相似试验

已完成
1 期
PBMC-therapy and treatment of recurrent implantation failure (RIF)
IRCT2017081227520N8Stem Cell And Regenerative Medicine Institute,Tabriz University of Medical Sciences100
尚未招募
2 期
Autologous cord blood-derived cell therapy for extremely preterm infants: An international, multicentre randomised controlled trialprematuritypreterm brain injuryReproductive Health and Childbirth - Complications of newbornNeurological - Other neurological disorders
ACTRN12624000968572Monash Health334
已完成
不适用
The impact of cell salvage on blood transfusion rates in major hepatobiliary surgeryColorectal liver metastasesIMPN pancreasSurgery - Other surgeryBlood - AnaemiaCancer - Biliary tree (gall bladder and bile duct)Cancer - LiverCancer - PancreaticHCC
ACTRN12623000161628Mr Alex Gordon-Weeks501
已完成
不适用
Autologous peripheral blood stem cell transplantation using Thiotepa, Carboplatin and Etoposide conditioning in patients with relapsed or refractory Medulloblastoma, Primitive neuroectodermal tumor (PNET) and Atypical teratoma and rhabdoid tumor (ATRT)relapsed or refractory Medulloblastoma, Primitive neuroectodermal tumor (PNET) and Atypical teratoma and rhabdoid tumor (ATRT)
JPRN-UMIN000026084agoya University Graduate School of Medicine10
已完成
不适用
Autologous peripheral blood stem cell transplantation as consolidation for high risk diffuse large B-cell lymphoma:A phase II studyDiffuse Large B-Cell Lymphoma:IPI high risk group, CR1
JPRN-UMIN000012546ishiwaki Municipal Hospital18